377 related articles for article (PubMed ID: 30975459)
1. Introducing a Spectrum of Long-Range Genomic Deletions in Human Embryonic Stem Cells Using Type I CRISPR-Cas.
Dolan AE; Hou Z; Xiao Y; Gramelspacher MJ; Heo J; Howden SE; Freddolino PL; Ke A; Zhang Y
Mol Cell; 2019 Jun; 74(5):936-950.e5. PubMed ID: 30975459
[TBL] [Abstract][Full Text] [Related]
2. Introducing Large Genomic Deletions in Human Pluripotent Stem Cells Using CRISPR-Cas3.
Hou Z; Hu C; Ke A; Zhang Y
Curr Protoc; 2022 Feb; 2(2):e361. PubMed ID: 35129865
[TBL] [Abstract][Full Text] [Related]
3. Genome Editing in Penicillium chrysogenum Using Cas9 Ribonucleoprotein Particles.
Pohl C; Mózsik L; Driessen AJM; Bovenberg RAL; Nygård YI
Methods Mol Biol; 2018; 1772():213-232. PubMed ID: 29754231
[TBL] [Abstract][Full Text] [Related]
4. A compact Cascade-Cas3 system for targeted genome engineering.
Csörgő B; León LM; Chau-Ly IJ; Vasquez-Rifo A; Berry JD; Mahendra C; Crawford ED; Lewis JD; Bondy-Denomy J
Nat Methods; 2020 Dec; 17(12):1183-1190. PubMed ID: 33077967
[TBL] [Abstract][Full Text] [Related]
5. Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems.
Tan R; Krueger RK; Gramelspacher MJ; Zhou X; Xiao Y; Ke A; Hou Z; Zhang Y
Mol Cell; 2022 Feb; 82(4):852-867.e5. PubMed ID: 35051351
[TBL] [Abstract][Full Text] [Related]
6. Genome editing via delivery of Cas9 ribonucleoprotein.
DeWitt MA; Corn JE; Carroll D
Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
[TBL] [Abstract][Full Text] [Related]
7. Harnessing type I CRISPR-Cas systems for genome engineering in human cells.
Cameron P; Coons MM; Klompe SE; Lied AM; Smith SC; Vidal B; Donohoue PD; Rotstein T; Kohrs BW; Nyer DB; Kennedy R; Banh LM; Williams C; Toh MS; Irby MJ; Edwards LS; Lin CH; Owen ALG; Künne T; van der Oost J; Brouns SJJ; Slorach EM; Fuller CK; Gradia S; Kanner SB; May AP; Sternberg SH
Nat Biotechnol; 2019 Dec; 37(12):1471-1477. PubMed ID: 31740839
[TBL] [Abstract][Full Text] [Related]
8. Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes.
Bruntraeger M; Byrne M; Long K; Bassett AR
Methods Mol Biol; 2019; 1961():153-183. PubMed ID: 30912046
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 mediated high efficiency knockout of the eye color gene Vermillion in Helicoverpa zea (Boddie).
Perera OP; Little NS; Pierce CA
PLoS One; 2018; 13(5):e0197567. PubMed ID: 29771955
[TBL] [Abstract][Full Text] [Related]
10. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
Wilbie D; Walther J; Mastrobattista E
Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
[TBL] [Abstract][Full Text] [Related]
11. Allosteric control of type I-A CRISPR-Cas3 complexes and establishment as effective nucleic acid detection and human genome editing tools.
Hu C; Ni D; Nam KH; Majumdar S; McLean J; Stahlberg H; Terns MP; Ke A
Mol Cell; 2022 Aug; 82(15):2754-2768.e5. PubMed ID: 35835111
[TBL] [Abstract][Full Text] [Related]
12. Identification of RNA Binding Partners of CRISPR-Cas Proteins in Prokaryotes Using RIP-Seq.
Sharma S; Sharma CM
Methods Mol Biol; 2022; 2404():111-133. PubMed ID: 34694606
[TBL] [Abstract][Full Text] [Related]
13. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
[TBL] [Abstract][Full Text] [Related]
14. Repetitive DNA Reeling by the Cascade-Cas3 Complex in Nucleotide Unwinding Steps.
Loeff L; Brouns SJJ; Joo C
Mol Cell; 2018 May; 70(3):385-394.e3. PubMed ID: 29706536
[TBL] [Abstract][Full Text] [Related]
15. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
Chen S; Lee B; Lee AY; Modzelewski AJ; He L
J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
[TBL] [Abstract][Full Text] [Related]
16. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
Liu GG; Li S; Wei YD; Zhang YX; Ding QR
Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
[TBL] [Abstract][Full Text] [Related]
17. Chimeric DNA-RNA Guide RNA Designs.
Lu S; Zhang Y; Yin H
Methods Mol Biol; 2021; 2162():79-85. PubMed ID: 32926379
[TBL] [Abstract][Full Text] [Related]
18. Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing.
Dubey S; Chen Z; Jiang YJ; Talis A; Molotkov A; Ali A; Mintz A; Momen-Heravi F
Theranostics; 2024; 14(7):2777-2793. PubMed ID: 38773978
[TBL] [Abstract][Full Text] [Related]
19. Preparation and electroporation of Cas12a/Cpf1-guide RNA complexes for introducing large gene deletions in mouse embryonic stem cells.
Kissling L; Monfort A; Swarts DC; Wutz A; Jinek M
Methods Enzymol; 2019; 616():241-263. PubMed ID: 30691645
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution and biochemical characterization of the RNA-guided helicase-nuclease protein Cas3 from type I-A CRISPR-Cas system.
Hu C; Ke A
Methods Enzymol; 2022; 673():405-424. PubMed ID: 35965014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]